Medizinprodukte-Nachrichten
Aktuelle Branchennachrichten, regulatorische Updates und Mitteilungen aus vertrauenswürdigen Quellen.
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
Vollständigen Artikel lesen →GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027. The post GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal appeare…
Vollständigen Artikel lesen →Autonomix secures Canadian patent for catheter-based technologies
Autonomix Medical has secured a new patent from the Canadian Intellectual Property Office covering its catheter-based tissue monitoring and therapy delivery technology. The post Autonomix secures Cana…
Vollständigen Artikel lesen →Averly Health launches in UK to advance cardiometabolic care
Averly aims to improve patient care and access tenets surrounding cardiometabolic conditions, including obesity and type 2 diabetes. The post Averly Health launches in UK to advance cardiometabolic ca…
Vollständigen Artikel lesen →First US commercial procedures completed with Emboline’s device
Emboline has reported the first commercial use of its Emboliner Embolic Protection System in the US during two procedures involving transcatheter aortic valve implantation. The post First US commercia…
Vollständigen Artikel lesen →"The Next Signal": Where Commercial Pharma Data Is Headed
"The Next Signal": Where Commercial Pharma Data Is Headed dwunderlin Mon, 10/05/2026 - 14:28 Thu, 10/22/2026 - 14:00 Resource Type Webinar Amy Crowe Stephan Dunning, MBA, MS Commercial teams see patie…
Vollständigen Artikel lesen →Edwards’ verstellbarer Herzklappen für Kinder erhält FDA-Zulassung
The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.
Vollständigen Artikel lesen →FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
Vollständigen Artikel lesen →